Sep 29, 2020 6:25am EDT Lexaria Receives Conditional Ethics Board Approval for Pilot Human Study Using DehydraTECH Technology in Delivering Antiviral Drugs
Sep 23, 2020 6:15am EDT Lexaria Receives Orders for 4.4 Million Servings of DehydraTECH-Enabled CBD Powders
Sep 16, 2020 6:25am EDT Lexaria Bioscience Supports Corporate Growth Initiatives by its Licensee, Cannadips CBD by the Boldt Runners Corporation
Jul 28, 2020 6:30am EDT Lexaria BioScience Receives Ethics Board Approval to Conduct Exploratory Clinical Study using Cannabidiol for Blood Pressure Reduction
Jul 21, 2020 6:15am EDT Lexaria BioScience Files Application with Senior U.S. Stock Exchange for Uplisting
Jun 29, 2020 4:15pm EDT Lexaria Bioscience Engages Investor Relations and Capital Markets Advisory Firm for its Shareholder Communications Program
